AbbVie, Bristol Myers Squibb, Boehringer Ingelheim and PhRMA are asking to intervene in the hospital industry’s lawsuit seeking to block HRSA’s revised 340B Rebate Model Pilot Program, according to court filings in the U.S. District Court for the District of…
The FDA has launched an initiative to develop a new regulatory framework for rare disease drugs and biologics, as only about 5% of rare conditions have an FDA-approved treatment. The Rare Disease Framework Initiative will consider the nuances of each…
Woodbridge, Va.-based Sentara Northern Virginia Medical Center has opened Sentara To Home, an outpatient pharmacy that allows patients to fill prescriptions before leaving the hospital. The pharmacy opened Oct. 14 and offers insurance assistance, medication cost evaluations and support for…
The FDA has approved Anktiva as the first treatment specifically for adults with BCG-unresponsive, high-grade papillary-only bladder cancer that has not spread into the bladder muscle. The expanded approval covers Anktiva (nogapendekin alfa inbakicept-pmln) given with Bacillus Calmette-Guérin, according to…
Merck CEO Rob Davis expects the personalized cancer vaccine the company is developing with Moderna to become faster to manufacture over time, according to an Oct. 14 CNBC report. The current turnaround is about six weeks, from sequencing a patient’s…
U.S. Customs and Border Protection is delaying new international mail entry requirements until Jan. 20, 2027. The requirements, previously set to take effect Oct. 22, had raised concerns that millions of Americans who buy prescription drugs from Canadian and other…
Pennsylvania Attorney General Dave Sunday has sued three insulin makers and several pharmacy benefit managers, alleging they colluded to manipulate insulin prices and raise patients’ out-of-pocket costs. The attorney general’s Antitrust Section filed the complaint in Commonwealth Court this week,…
The FDA has recently approved five treatments, including new drugs, a new injectable formulation and expanded uses for two cancer and skin therapies. Here are the five to know:
U.S. drug distribution revenues for Cencora, Cardinal Health and McKesson are projected to reach $933 billion in 2026 as changes in drug pricing, 340B and specialty pharmacy reshape the distribution market, according to an Oct. 14 Drug Channels analysis. Here…
Aurobindo Pharma USA has initiated a nationwide recall of Amazon-branded Extra Strength Acetaminophen, 500 milligrams, after consumer complaints of discolored tablets. The voluntary, firm-initiated recall began Sept. 18 and remains ongoing, according to an FDA enforcement report. The products were…
